MLICM
AKCA

Metropolitan Life Insurance Company (MetLife)’s Akcea Therapeutics Inc AKCA Stock Holding History

Metropolitan Life Insurance Company (MetLife)’s Portfolio AKCA Stock Details AKCA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-5,455
Closed -$99K – 2610
2020
Q3 		$99K Buy
5,455
+543
+11% +$7.7K ﹤0.01% 2223
2020
Q2 		$67.3K Hold
4,912
– – ﹤0.01% 2455
2020
Q1 		$70.2K Sell
4,912
-96
-2% -$1.58K ﹤0.01% 2248
2019
Q4 		$84.8K Hold
5,008
– – ﹤0.01% 2416
2019
Q3 		$77.1K Hold
5,008
– – ﹤0.01% 2439
2019
Q2 		$117K Hold
5,008
– – ﹤0.01% 2222
2019
Q1 		$142K Hold
5,008
– – ﹤0.01% 2116
2018
Q4 		$151K Hold
5,008
– – ﹤0.01% 2003
2018
Q3 		$175K Buy
+5,008
New +$152K ﹤0.01% 2086
2018
Q2 		– Sell
-5,008
Closed -$128K – 2515
2018
Q1 		$128K Sell
5,008
-610
-11% -$13.1K ﹤0.01% 2165
2017
Q4 		$98K Sell
5,618
-10,911
-66% -$214K ﹤0.01% 2322
2017
Q3 		$457K Buy
+16,529
New +$306K ﹤0.01% 1749

Metropolitan Life Insurance Company (MetLife)'s AKCA Position: Q4 2020 in Review

Metropolitan Life Insurance Company (MetLife) sold out of Akcea Therapeutics Inc (AKCA) in Q4 2020, closing a stake of 5,455 shares — an estimated $99K sold.

Metropolitan Life Insurance Company (MetLife) first reported a position in AKCA in Q3 2017 and held it in 12 quarters. The position peaked at $457K in Q3 2017. 0 funds tracked by Wall St. Rank hold AKCA as of Q4 2020.

  • Metropolitan Life Insurance Company (MetLife) reported no remaining Akcea Therapeutics Inc position as of Q4 2020 after selling out during the quarter.
  • Metropolitan Life Insurance Company (MetLife) sold 5,455 Akcea Therapeutics Inc shares in Q4 2020, an estimated $99K.
  • Metropolitan Life Insurance Company (MetLife) first reported a position in Akcea Therapeutics Inc in Q3 2017 and held it in 12 quarters.
  • Metropolitan Life Insurance Company (MetLife)'s Akcea Therapeutics Inc position peaked at $457K in Q3 2017.
  • 0 funds tracked by Wall St. Rank held Akcea Therapeutics Inc as of Q4 2020.

Based on Metropolitan Life Insurance Company (MetLife)'s 13F filing for Q4 2020, filed 16 Feb 2021.